140,18 €
0,67 %
L&S, 7. Februar, 22:54 Uhr
ISIN
GB0009895292
Symbol
AZN
Sektor
Industrie

AstraZeneca Aktie News

AD HOC NEWS
4 Tage alt
Der Pharmakonzern Astrazeneca GB0009895292 hat sich dank eines überraschend starken Schlussspurts im vergangenen Jahr besser geschlagen als gedacht.
Neutral
PRNewsWire
4 Tage alt
NEW YORK , Feb. 5, 2025 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AstraZeneca PLC (NASDAQ: AZN) between February 23, 2022 and December 17, 2024, both dates inclusive (the "Class Period"), of the February 21, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. So what: If you purchased AstraZeneca...
Neutral
Accesswire
5 Tage alt
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In AstraZenecaTo Contact Him Directly To Discuss Their Options NEW YORK CITY, NY / ACCESS Newswire / February 5, 2025 / If you purchased or acquired securities in AstraZeneca between February 23, 2022 and December 17, 2024 and would like to discuss your legal rights, call Faruqi & Far...
Negativ
Reuters
5 Tage alt
AstraZeneca investors will look past another strong set of quarterly results on Thursday to focus on the main issue overhanging shares: an investigation of a top executive by authorities in China, one of its key markets.
Neutral
PRNewsWire
6 Tage alt
LOS ANGELES , Feb. 4, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to AstraZeneca PLC ("AstraZeneca" or the "Company") (NASDAQ: AZN) have opportunity to lead the securities fraud class action lawsuit.
Negativ
Reuters
7 Tage alt
Britain on Monday hit back at AstraZeneca over the collapse of a 450 million pound ($558.5 million) investment, saying the drugmaker had scaled back the research and development portion of its plans, resulting in a lower offer of government support.
Negativ
Proactive Investors
7 Tage alt
AstraZeneca PLC (LSE:AZN) shares fell slightly on Monday after reports that it had shelved a £450 million vaccine manufacturing plant extension in northwest England, turning down £80 million of government support. In co-announced plans last year, the FTSE 100's largest company said it would plough £650 million into a vaccine manufacturing facility in Liverpool alongside the expansion of an exis...
Neutral
PRNewsWire
8 Tage alt
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In AstraZenecaTo Contact Him Directly To Discuss Their Options If you purchased or acquired securities in AstraZeneca between between February 23, 2022 and December 17, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 ...
Mehr News anzeigen

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen